Participants will be administered local anesthesia of 0.5 percent of Bupivacaine v/s 4 percent Articaine to compare the success rate of both anesthetic agents in teeth with Symptomatic Irreversible Pulpitis

To evaluate the success rate of 0.5 percent Bupivacaine v/s 4 percent Articaine as anesthetic agents in teeth with Symptomatic Irreversible Pulpitis - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076367

Enrollment

Registered

2024-11-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified

Interventions

Intervention1: BUPIVACAINE: Bupivacaine will be given in IANB nerve block with the dose of 1.8 mL to evaluate the success rate end effectivity of anesthesia Control Intervention1: ARTICAINE: Articaine

Eligibility

Inclusion criteria

Inclusion criteria: Systemically healthy patients. Mature permanent mandibular posteriors with symptomatic irreversible pulpitis with no periapical radiolucency Teeth having sufficient tooth structure for adequate isolation. A vital coronal pulp on access opening No history of previous endodontic therapy. No history of trauma to the involved tooth.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain Control and Effectivity with Bupivacaine and ArticaineTimepoint: Before administration of local anesthesia, 15 minutes after administration of anesthesia, during instrumentation	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR MAMTA SINGLA

SGT DENTAL COLLEGE HOSPITAL AND RESEARCH INSTITUTE,SGT UNIVERSITY

mamta.singla@sgtuniversity.org9891381349

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026